1.Risk factors predicting development of complications in 72 dogs with esophageal foreign bodies
Bohye SHIN ; Hakhyun KIM ; Dongwoo CHANG ; Ji Houn KANG ; Byeong Teck KANG ; Mhan pyo YANG
Korean Journal of Veterinary Research 2019;59(1):25-31
The aim of this study was to determine predictive risk factors implicated in complications in dogs with esophageal foreign bodies. Medical records of 72 dogs diagnosed with esophageal foreign bodies by endoscopy were reviewed retrospectively. Factors analyzed included age; breed; gender; body weight, location, dimension, and type of foreign body; and duration of impaction. To identify risk factors associated with complications after foreign body ingestion, categorical variables were analyzed using the chi-square or Fisher's exact tests and multivariate analysis, as appropriate. Complications secondary to esophageal foreign body ingestion included megaesophagus, esophagitis, perforation, laceration, diverticulum, and pleuritis. Univariate analysis revealed that the location and duration of impaction after foreign body ingestion were associated with an increased risk of esophageal laceration and perforation. Multivariate analysis showed that age, duration of impaction, and foreign body dimension were significant independent risk factors associated with the development of complications in dogs with esophageal foreign bodies. In conclusion, these results showed that longer duration of impaction and larger foreign body dimensions may increase the risks of esophageal laceration, perforation, and plueritis in dogs.
Animals
;
Body Weight
;
Diverticulum
;
Diverticulum, Esophageal
;
Dogs
;
Eating
;
Endoscopy
;
Esophageal Achalasia
;
Esophageal Perforation
;
Esophagitis
;
Foreign Bodies
;
Lacerations
;
Medical Records
;
Multivariate Analysis
;
Pleurisy
;
Retrospective Studies
;
Risk Factors
2.Traditional Medicine Doctor Kim Gwangjin's Battle against Jaundice during the Japanese Colonial Period
Korean Journal of Medical History 2019;28(2):427-468
This study aims to examine how traditional medicine doctors (醫生) of the Japanese colonial period in Korea treated patients and their own diseases with traditional medicine (漢方) and Western medicine (洋方) by analyzing Clinical Cases (治案) and A Diary of Jaundice Treatment (治疸日記) of Kim Gwangjin (金光鎭, 1885–1940). Through this inquiry, this study aims to reveal that the Japanese colonial period was a time when the traditional medicine and the Western medicine coexisted, and that this period cannot be simply defined as a dualism between “Western medicine, Japanese colonial government” versus “traditional medicine, governed public.” Kim Gwangjin's main method of medical treatment was traditional medicine. Clinical Cases include over 60 treatment cases, and they illustrate that he was a typical doctor at the time using traditional medical knowledge. In addition, Kim wrote A Diary of Jaundice Treatment from January 1939 to July 1940, a month before his death. The disease that led to his death was jaundice. He examined the changes in his abdomen every day, and recorded the changes in edema in upper extremities and testicles, urine and feces. While the treatment that Kim used in the early stages of jaundice were herbal medicines, he was not confined to the boundaries of the traditional medicine as he studied Western medicine to obtain a license of traditional medicine doctor from Japanese colonial government. He took a urine test to confirm whether his illness was jaundice or kidney disease and had X-ray imaging to check for pleurisy at a Western medical hospital in Daegu. Furthermore, he received a procedure to artificially drain bile, took a medicine to excrete bile into the feces, and had injection to treat neuralgia. Mostly, it was diarrhea that bothered Kim, who had been suffering from jaundice. Preventing diarrhea led to edema, and removing edema led to diarrhea again. He managed his symptoms by stopping the herbal medicine treatments and going on a raw food diet. Around this time, Kim relied the most on Ejisan (エヂ散). Ejisan was a type of new medicine mixed with traditional medicine and Western medicine that had the effect of treating edema and digestive disorders. Kim personally manufactured and took the drug until a month before his death, praising it as a necessary drug to treat jaundice. Kim was a traditional medical doctor during the Japanese colonial period. He also had the conventional wisdom that Western medicine was excellent in treating surgical diseases but not effective in internal medicine. However, he used both traditional medicine and Western medicine to treat symptoms of jaundice that have not been treated well and created a new medicine called Ejisan, which combined the two types of medicines. For him, Western medicine was a new medicine that improved the wrong aspects of traditional medicine or the old medicine, but there was still a realm of traditional medicine that Western medicine could not intervene. Furthermore, he published a new theory of traditional medicine called the Principle of Up and Down (升降論), which incorporates some Western medical knowledge. The Japanese colonial government required traditional medicine doctors to study Western medicine, and traditional medicine doctors had to learn Western medicine in order to survive. In the meantime, traditional medicine doctors such as Kim have brought about new changes by integrating the two medical treatments in the clinical field. The Japanese colonial government planned the demise of traditional medicine by forcing traditional medicine doctors to study the Western medicine, but the unexpected achievement brought about by traditional medicine doctors, who survived longer than the Japanese Empire and the colonial government, was an attempt to integrate Eastern and Western medicine.
Abdomen
;
Asian Continental Ancestry Group
;
Bile
;
Daegu
;
Diarrhea
;
Diet
;
Edema
;
Feces
;
Herbal Medicine
;
Humans
;
Internal Medicine
;
Jaundice
;
Kidney Diseases
;
Korea
;
Licensure
;
Medicine, Traditional
;
Methods
;
Neuralgia
;
Pleurisy
;
Raw Foods
;
Testis
;
Upper Extremity
3.In silico analysis of putative drug and vaccine targets of the metabolic pathways of Actinobacillus pleuropneumoniae using a subtractive/comparative genomics approach
Biruk T BIRHANU ; Seung Jin LEE ; Na Hye PARK ; Ju Beom SONG ; Seung Chun PARK
Journal of Veterinary Science 2018;19(2):188-199
Actinobacillus pleuropneumoniae is a Gram-negative bacterium that resides in the respiratory tract of pigs and causes porcine respiratory disease complex, which leads to significant losses in the pig industry worldwide. The incidence of drug resistance in this bacterium is increasing; thus, identifying new protein/gene targets for drug and vaccine development is critical. In this study, we used an in silico approach, utilizing several databases including the Kyoto Encyclopedia of Genes and Genomes (KEGG), the Database of Essential Genes (DEG), DrugBank, and Swiss-Prot to identify non-homologous essential genes and prioritize these proteins for their druggability. The results showed 20 metabolic pathways that were unique and contained 273 non-homologous proteins, of which 122 were essential. Of the 122 essential proteins, there were 95 cytoplasmic proteins and 11 transmembrane proteins, which are potentially suitable for drug and vaccine targets, respectively. Among these, 25 had at least one hit in DrugBank, and three had similarity to metabolic proteins from Mycoplasma hyopneumoniae, another pathogen causing porcine respiratory disease complex; thus, they could serve as common therapeutic targets. In conclusion, we identified glyoxylate and dicarboxylate pathways as potential targets for antimicrobial therapy and tetra-acyldisaccharide 4′-kinase and 3-deoxy-D-manno-octulosonic-acid transferase as vaccine candidates against A. pleuropneumoniae.
Actinobacillus pleuropneumoniae
;
Actinobacillus
;
Computer Simulation
;
Cytoplasm
;
Databases, Protein
;
Drug Resistance
;
Genes, Essential
;
Genome
;
Genomics
;
Incidence
;
Metabolic Networks and Pathways
;
Mycoplasma hyopneumoniae
;
Pleuropneumonia
;
Respiratory System
;
Swine
;
Transferases
4.Bee venom stimulation of a lung meridian acupoint reduces inflammation in carrageenan-induced pleurisy: an alternative therapeutic approach for respiratory inflammation
Hoon Seong CHOI ; Suk Yun KANG ; Dae Hyun ROH ; Sheu Ran CHOI ; Yeonhee RYU ; Jang Hern LEE
Journal of Veterinary Science 2018;19(5):708-715
Respiratory inflammation is a frequent and fatal pathologic state encountered in veterinary medicine. Although diluted bee venom (dBV) has potent anti-inflammatory effects, the clinical use of dBV is limited to several chronic inflammatory diseases. The present study was designed to propose an acupoint dBV treatment as a novel therapeutic strategy for respiratory inflammatory disease. Experimental pleurisy was induced by injection of carrageenan into the left pleural space in mouse. The dBV was injected into a specific lung meridian acupoint (LU-5) or into an arbitrary non-acupoint located near the midline of the back in mouse. The inflammatory responses were evaluated by analyzing inflammatory indicators in pleural exudate. The dBV injection into the LU-5 acupoint significantly suppressed the carrageenan-induced increase of pleural exudate volume, leukocyte accumulation, and myeloperoxidase activity. Moreover, dBV acupoint treatment effectively inhibited the production of interleukin 1 beta, but not tumor necrosis factor alpha in the pleural exudate. On the other hand, dBV treatment at non-acupoint did not inhibit the inflammatory responses in carrageenan-induced pleurisy. The present results demonstrate that dBV stimulation in the LU-5 lung meridian acupoint can produce significant anti-inflammatory effects on carrageenan-induced pleurisy suggesting that dBV acupuncture may be a promising alternative medicine therapy for respiratory inflammatory diseases.
Acupuncture
;
Acupuncture Points
;
Animals
;
Bee Venoms
;
Bees
;
Carrageenan
;
Complementary Therapies
;
Exudates and Transudates
;
Hand
;
Inflammation
;
Interleukin-1beta
;
Leukocytes
;
Lung
;
Mice
;
Peroxidase
;
Pleurisy
;
Tumor Necrosis Factor-alpha
;
Veterinary Medicine
5.Loculated Tuberculous Pleural Effusion: Easily Identifiable and Clinically Useful Predictor of Positive Mycobacterial Culture from Pleural Fluid.
Yousang KO ; Changhwan KIM ; Boksoon CHANG ; Suh Young LEE ; So Young PARK ; Eun Kyung MO ; Su Jin HONG ; Myung Goo LEE ; In Gyu HYUN ; Yong Bum PARK
Tuberculosis and Respiratory Diseases 2017;80(1):35-44
BACKGROUND: Isolation of M. tuberculosis (MTB) is required in cases of Tuberculous pleural effusion (TBPE) for confirming diagnosis and successful therapy based on drug sensitivity test. Several studies have focused on predictors of MTB culture positivity in TBPE. However, the clinical role of loculated TBPE as a predictor of MTB cultivation from TBPE remains unclear. The aim of this study was to examine possible predictors including loculation of TBPE of MTB culture positivity in TBPE. METHODS: We retrospectively examined associations between clinical, radiological, microbiological, and laboratory characteristics and positive MTB culture from TBPE to determine a potent predictor of culture positivity. RESULTS: From January 2011 to August 2015, 232 patients with TBPE were identified. Of these, 219 were finally analyzed. Among them, 69 (31.5%) were culture positive for MTB in TBPE and 86 (39.3%) had loculated TBPE. In multivariate logistic regression analysis, the loculation of TBPE was independently associated with culture positivity for MTB in TBPE (adjusted odds ratio [OR], 40.062; 95% confidence interval [CI], 9.355–171.556; p<0.001). In contrast, the lymphocyte percentage of TBPE (adjusted OR, 0.934; 95% CI, 0.899–0.971; p=0.001) was inversely associated with culture positivity for MTB in TBPE. CONCLUSION: In clinical practice, identification of loculation in TBPE is easy, reliable to measure, not uncommon and may be helpful to predict the possibility of positive mycobacterial culture.
Diagnosis
;
Humans
;
Logistic Models
;
Lymphocytes
;
Odds Ratio
;
Pleural Effusion*
;
Pleurisy
;
Retrospective Studies
;
Tuberculosis
6.Corticosteroid Therapy for Refractory Uremic Pleurisy.
Eun Ji PARK ; Min A PARK ; Myung Jae PARK ; So Young PARK ; Seung Hyeun LEE
The Ewha Medical Journal 2016;39(4):125-128
Uremic pleuritis is a fibrinous pleuritis of unknown pathogenesis in patients with chronic kidney disease. Although it responds to regular dialysis or repeated thoracentesis, cases that are refractory to those therapies have been reported. We report a case of uremic pleuritis which showed marked improvement following corticosteroid therapy. The effusion was exudate, and negative in cytology and microbiology. Pleural biopsy revealed chronic inflammation with fibrosis. The pleural effusion did not respond to chest tube drainage and continuance of hemodialysis. With a diagnosis of refractory uremic pleuritis, we started methylprednisolone. The pleural effusion responded to the treatment and resolved without complication.
Biopsy
;
Chest Tubes
;
Diagnosis
;
Dialysis
;
Drainage
;
Exudates and Transudates
;
Fibrin
;
Fibrosis
;
Humans
;
Inflammation
;
Methylprednisolone
;
Pleural Effusion
;
Pleurisy*
;
Renal Dialysis
;
Renal Insufficiency, Chronic
;
Thoracentesis
;
Uremia
7.Diffuse Large B-cell Lymphoma Arising from Chronic Tuberculous Empyema.
Ju Sik YUN ; Seung Ku KANG ; Jo Heon KIM ; Yochun JUNG ; Yoo Duk CHOI ; Sang Yun SONG
The Korean Journal of Thoracic and Cardiovascular Surgery 2015;48(1):82-85
Pyothorax-associated lymphoma is a relatively rare type of lymphoma that occurs in patients who have long histories of tuberculous pleuritis or induced pneumothorax. It is a type of non-Hodgkin's lymphoma of mainly the B-cell phenotype and is strongly associated with Epstein-Barr virus infection. A majority of these cases have been reported in Japan, although some cases have occurred in Western countries. Here, we describe a case of pyothorax-associated lymphoma in a patient with a 30-year history of chronic tuberculous empyema. The patient underwent decortication under the impression of chronic empyema with fistula. The histopathologic diagnosis was a diffuse large B-cell lymphoma associated chronic inflammation.
B-Lymphocytes
;
Diagnosis
;
Empyema
;
Empyema, Tuberculous*
;
Fistula
;
Herpesvirus 4, Human
;
Humans
;
Inflammation
;
Japan
;
Lung
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, Non-Hodgkin
;
Phenotype
;
Pleurisy
;
Pneumothorax
8.Clinical value of pleural biopsy in the etiological diagnosis of children with pleurisy.
Hongmei NIE ; Jin ZHU ; Yong AN ; Jihong DAI
Chinese Journal of Pediatrics 2015;53(3):178-181
OBJECTIVETo investigate the clinical value of pleural biopsy in the etiological diagnosis of pleurisy in children.
METHODTotally 213 cases with pleurisy, who underwent pleural biopsy and hospitalized in Children's Hospital of Chongqing Medical University from January 2007 to April 2014 were enrolled into this study. Clinical symptoms, imaging manifestations, pleural fluid characteristics, the results of pleural biopsy and postoperative complications were retrospectively analyzed to evaluate the clinical value and security of pleural biopsy in making the etiological diagnosis of pleurisy.
RESULT(1) Of the 213 cases, 144 were boys and 69 were girls, their mean age was (6. 5 ± 4. 1) years. (2) Two hundred and thirteen patients had a surgical pleural biopsy under general anesthesia, the cause of 97 cases (45. 5%) were made clear by histopathological examination, including 35 purulent pleurisy, 55 tuberculous pleurisy and 7 paragonimus infection. For the remaining 83 (41. 3%) cases a final diagnosis was made based on the full analysis of clinical data, including 63 cases of purulent pleurisy, 3 cases of tuberculous pleurisy and 17 cases of paragonimiasis pleurisy but for 33 patients no exact cause was found at the end. (3) The mean operating time of the biopsy was (1. 4 ± 0. 6) hours. Seventy one (33. 3%) patients required blood transfusion during or after the operation. Thirty one (14. 6%) cases used the ventilator after surgery, and the ventilator supporting time was (6. 6 ± 5. 8) hours on average. The wound healing reached grade A in 200 cases (93. 9%), grade B in 13 cases (14. 6%). Postoperative complications included pneumothorax in 92 cases (43. 2%), subcutaneous emphysema in 18 cases (8. 5%), bronchopleural fistula in 3 cases(1. 4%). The average days of hospitalization was (17. 7 ± 7. 1) d.
CONCLUSIONPleural biopsy is of great diagnostic value in the etiological diagnosis and differential diagnosis of pleurisy in children, and it is considered reasonable to be used in the clinical practice when appropriate.
Biopsy ; Child ; Diagnosis, Differential ; Female ; Humans ; Infection ; diagnosis ; Male ; Pleura ; Pleurisy ; diagnosis ; etiology ; Retrospective Studies ; Tuberculosis, Pleural ; complications ; diagnosis
9.Prevalence and Characterization of Actinobacillus pleuropneumoniae Isolated from Korean Pigs.
Ki Eun LEE ; Hwan Won CHOI ; Ha Hyun KIM ; Jae Young SONG ; Dong Kun YANG
Journal of Bacteriology and Virology 2015;45(1):19-25
Actinobacillus pleuropneumoniae causes porcine pleuropneumoniae which is one of severe threats to the swine industry. In total, 54 strains of Actinobacillus pleuropneumoniae were isolated from 443 pigs between 2012 and 2013 in Korea. Isolates were classified into serotypes 1, 2, 5, 7, 12, and unclassified by multiplex PCR. Genotypes of isolates were divided into three groups according to the sequence of the omlA gene. The antimicrobial resistance rate of serotype 1 was slightly higher than that of serotype 5. In conclusion, to block and treat porcine pleuropneumonia, it is necessary to conduct ongoing characterization of A. pleuropneumoniae isolated from pigs.
Actinobacillus pleuropneumoniae*
;
Genotype
;
Korea
;
Multiplex Polymerase Chain Reaction
;
Pleuropneumonia
;
Prevalence*
;
Swine*
10.Current Concepts in Primary Effusion Lymphoma and Other Effusion-Based Lymphomas.
Yoonjung KIM ; Chan Jeong PARK ; Jin ROH ; Jooryung HUH
Korean Journal of Pathology 2014;48(2):81-90
Primary effusion lymphoma (PEL) is a human herpes virus 8 (HHV8)-positive large B-cell neoplasm that presents as an effusion with no detectable tumor in individuals with human immunodeficiency virus infection or other immune deficiencies. PEL is an aggressive neoplasm with a poor prognosis. PEL cells show diverse morphologies, ranging from immunoblastic or plasmablastic to anaplastic. The immunophenotype of PEL is distinct, but its lineage can be misdiagnosed if not assessed thoroughly. PEL cells usually express CD45, lack B- and T-cell-associated antigens, and characteristically express lymphocyte activation antigens and plasma cell-associated antigens. Diagnosis of PEL often requires the demonstration of a B-cell genotype. HHV8 must be detected in cells to diagnose PEL. In most cases, PEL cells also harbor the Epstein-Barr virus (EBV) genome. Similar conditions associated with HHV8 but not effusion-based are called "extracavitary PELs." PELs should be differentiated from HHV8-negative, EBV-positive, body cavity-based lymphomas in patients with long-standing chronic inflammation; the latter can occur in tuberculous pleuritis, artificial pneumothorax, chronic liver disease and various other conditions. Despite their morphological similarity, these various lymphomas require different therapeutic strategies and have different prognostic implications. Correct diagnosis is essential to manage and predict the outcome of patients with PEL and related disorders.
B-Lymphocytes
;
Diagnosis
;
Genome
;
Genotype
;
Herpesvirus 4, Human
;
HIV
;
Humans
;
Inflammation
;
Liver Diseases
;
Lymphocyte Activation
;
Lymphoma*
;
Lymphoma, Primary Effusion*
;
Plasma
;
Pleurisy
;
Pneumothorax, Artificial
;
Prognosis

Result Analysis
Print
Save
E-mail